No Data
No Data
No Data
No Data
No Data
Changes in Hong Kong stocks | Dongyangguang Changjiang Pharmaceutical (01558) is now up more than 3%, and the procurement price of insulin is more moderate. The company plans to win the bid for 5 products
Dongyangguang Changjiang Pharmaceutical (01558) is now up more than 3%. As of press release, it is up 3.15% to HK$12.46, with a turnover of HK$18.895 million.
Zhitong FinanceApr 25 02:40 ET
Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger With Sunshine Lake Pharma
Yichang Hec Changjiang Pharmaceutical Co (HKG:1558) and Sunshine Lake Pharma jointly said that they are looking into the possibilities of a merger, according to a Monday Hong Kong bourse. A definitive
MT NewswiresApr 9 01:16 ET
Dongyangguang Changjiang Pharmaceutical (01558): The potential offender has not proposed a clear plan for the possible merger to the company
Dongyangguang Changjiang Pharmaceutical (01558) issued an announcement. Guangdong Dongyangyang Pharmaceutical Co., Ltd. (potential offender) announced...
Zhitong FinanceApr 8 05:37 ET
Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps
Yichang Hec Changjiang Pharmaceutical's (HKG:1558) net profit attributable to equity holders surged to 1.99 billion yuan in 2023 from 76.6 million yuan in 2022, according to a filing made with the Hon
MT NewswiresMar 31 23:36 ET
YiChang HEC ChangJiang Pharmaceutical's Profit Surges in 2023
YiChang HEC ChangJiang Pharmaceutical Co's (HKG:1558) net profit attributable to shareholders rose 2,501% to 2 billion yuan in the year ended Dec. 31, 2023, from 77 million yuan a year ago, according
MT NewswiresMar 28 22:43 ET
HEC CJ PHARM: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Futu NewsMar 28 06:09 ET · Announcements
No Data
No Data